David M. Loeb, MD, PhD

David M. Loeb, MD, PhD, is chief of the Division of Pediatric Hematology, Oncology, and Cellular Therapy Children’s Hospital at Montefiore. He is also a professor in the Department of Pediatrics (Pediatric Hematology-Oncology) and Department of Development & Molecular Biology at Albert Einstein College of Medicine, and a member of Montefiore Einstein Comprehensive Cancer Center in Bronx, NY.

Articles by David M. Loeb, MD, PhD

DFMO shows promise in reducing metastasis in osteosarcoma and Ewing sarcoma, with phase 2 trials underway to test its role as maintenance therapy.

From the Lab to the Clinic: Exploring DFMO’s Potential to Prevent Metastatic Disease in Children With Osteosarcoma and Ewing Sarcoma

ByDavid M. Loeb, MD, PhD,Rachel Offenbacher, MD

October 1st 2025

DFMO shows promise in reducing metastasis in osteosarcoma and Ewing sarcoma, with phase 2 trials underway to test its role as maintenance therapy.

David M. Loeb, MD, PhD

Articles by David M. Loeb, MD, PhD

From the Lab to the Clinic: Exploring DFMO’s Potential to Prevent Metastatic Disease in Children With Osteosarcoma and Ewing Sarcoma

Latest Updated Articles

Trending on OncLive

FDA Approves Orca-T for Matched Donor HSCT in Hematologic Malignancies

Frontline Treatment Selection in EGFR-Mutated Non-Small Cell Lung Cancer: Monotherapy Versus Combination Strategies

As ADC Options Expand, Sequencing and Toxicity Management Become the Next Challenges in Gynecologic Oncology

GLP-1 Receptor Agonists, Endocrine Therapy, and Metabolic Health Comprise Holistic Breast Cancer Care

First-Line CNS Efficacy in EGFR-Mutated NSCLC: FLAURA2 and MARIPOSA Data